Anticorps PLCG 2

9 produits

PLCG 2 est un gène codé par le symbole PLCG2. Communément appelé aussi: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2; Phosphoinositide phospholipase C-gamma-2; Phospholipase C-IV; PLC-IV; Phospholipase C-gamma-2; PLC-gamma-2; PLCG2. PLCG 2 a une masse de 147.87kDa, une longueur d'acide aminé de 1265, et est impliqué dans les maladies: Familial cold autoinflammatory syndrome 3; Autoinflammation, antibody deficiency, and immune dysregulation PLCG2-associated.

Nous proposons 9 des anticorps contre PLCG 2, élevé dans Lapin, qui sont appropriés pour le WB, IHC, ELISA et ICC/IF avec des échantillons dérivés de Humain, Souris et Rat.

Informations sur les Gènes et les Protéines

Résumé UniProt
The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. It is a crucial enzyme in transmembrane signaling.
Résumé Entrez
The protein encoded by this gene is a transmembrane signaling enzyme that catalyzes the conversion of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate to 1D-myo-inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) using calcium as a cofactor. IP3 and DAG are second messenger molecules important for transmitting signals from growth factor receptors and immune system receptors across the cell membrane. Mutations in this gene have been found in autoinflammation, antibody deficiency, and immune dysregulation syndrome and familial cold autoinflammatory syndrome 3.
Implication dans la maladie
Familial cold autoinflammatory syndrome 3: An autosomal dominant immune disorder characterized by the development of cutaneous urticaria, erythema, and pruritis in response to cold exposure. Affected individuals have variable additional immunologic defects, including antibody deficiency, decreased numbers of B-cells, defective B-cells, increased susceptibility to infection, and increased risk of autoimmune disorders.

Autoinflammation, antibody deficiency, and immune dysregulation PLCG2-associated: An autosomal dominant systemic disorder characterized by recurrent blistering skin lesions with a dense inflammatory infiltrate and variable involvement of other tissues, including joints, the eye, and the gastrointestinal tract. Affected individuals have a mild humoral immune deficiency associated with recurrent sinopulmonary infections, but no evidence of circulating autoantibodies.
Modification post-traductionnelle
Phosphorylated on tyrosine residues by CSF1R (By similarity). Phosphorylated on tyrosine residues by BTK and SYK; upon ligand-induced activation of a variety of growth factor receptors and immune system receptors. Phosphorylation leads to increased phospholipase activity.
Western Blot - Anti-PLCG2 (phospho Tyr753) Antibody (A0081) - Antibodies.com
(4)
Voir le roduitTaille d'Essai de 10µg
Western Blot - Anti-PLCG2 (phospho Tyr1217) Antibody (A0553) - Antibodies.com
(3)
Voir le roduitTaille d'Essai de 10µg
Western Blot - Anti-PLCG 2 Antibody [ARC1176] (A308453) - Antibodies.com
(4)
Western Blot - Anti-PLCG2 Antibody (B0081) - Antibodies.com
(3)
Voir le roduitTaille d'Essai de 10µg
Antibodies.com Image Placeholder - Discover more for less
Voir le roduitTaille d'Essai de 10µg
Western Blot - Anti-PLCG 2 (phospho Tyr1217) Antibody (A88327) - Antibodies.com
(2)
Western Blot - Anti-PLCG 2 Antibody (A13937) - Antibodies.com
(2)
Western Blot - Anti-PLCG 2 (phospho Tyr759) Antibody (A88328) - Antibodies.com
(2)
Antibodies.com Image Placeholder - Discover more for less

Affichage de 1-9 sur 9 produits

Filtres Menu Principal Nous Contacter 0Caisse
Haut